Human Interferon-induced guanylate-binding protein 1(GBP1) ELISA kit

Code CSB-EL009297HU
Size 96T,5×96T,10×96T
Trial Size 24T ELISA kits trial application
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Target Name guanylate binding protein 1, interferon-inducible, 67kDa
Alternative Names GBP 1 ELISA Kit; GBP-1 ELISA Kit; GBP1 ELISA Kit; GBP1_HUMAN ELISA Kit; GTP binding protein 1 ELISA Kit; GTP-binding protein 1 ELISA Kit; Guanine nucleotide binding protein 1 ELISA Kit; Guanine nucleotide-binding protein 1 ELISA Kit; Guanylate binding protein 1 ELISA Kit; Guanylate binding protein 1 interferon inducible 67kDa ELISA Kit; Guanylate binding protein 1 interferon inducible ELISA Kit; HuGBP 1 ELISA Kit; HuGBP-1 ELISA Kit; HuGBP1 ELISA Kit; Interferon induced guanylate binding protein 1 ELISA Kit; Interferon-induced guanylate-binding protein 1 ELISA Kit; OTTHUMP00000012352 ELISA Kit
Abbreviation GBP1
Uniprot No. P32455
Species Homo sapiens (Human)
Sample Types serum, plasma, tissue homogenates, cell lysates
Detection Range 25 pg/mL-1600 pg/mL
Sensitivity 6.25 pg/mL
Assay Time 1-5h
Sample Volume 50-100ul
Detection Wavelength 450 nm
Research Area Immunology
Assay Principle quantitative
Measurement Sandwich
Intra-assay Precision (Precision within an assay): CV%<8%      
Three samples of known concentration were tested twenty times on one plate to assess.  
Inter-assay Precision (Precision between assays): CV%<10%      
Three samples of known concentration were tested in twenty assays to assess.    
To assess the linearity of the assay, samples were spiked with high concentrations of human GBP1 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
  Sample Serum(n=4)  
1:1 Average % 86  
Range % 82-92  
1:2 Average % 98  
Range % 94-105  
1:4 Average % 97  
Range % 93-110  
1:8 Average % 94  
Range % 87-98  
The recovery of human GBP1 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
Sample Type Average % Recovery Range  
Serum (n=5) 95 90-98  
EDTA plasma (n=4) 98 91-100  
Typical Data
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
pg/ml OD1 OD2 Average Corrected  
1600 1.794 1.952 1.873 1.778  
800 1.175 1.101 1.138 1.043  
400 0.634 0.604 0.619 0.524  
200 0.351 0.339 0.345 0.250  
100 0.275 0.270 0.273 0.178  
50 0.195 0.192 0.194 0.099  
25 0.142 0.140 0.141 0.046  
0 0.095 0.094 0.095    
and FAQs
Storage Store at 2-8°C. Please refer to protocol.
Lead Time 7-14 working days

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Earn $30 Amazon Card or 20μL/μg CUSABIO Trial Size Antibody. Details of rewards >>

Target Data

Function Hydrolyzes GTP to GMP in 2 consecutive cleavage reactions. Exhibits antiviral activity against influenza virus. Promote oxidative killing and deliver antimicrobial peptides to autophagolysosomes, providing broad host protection against different pathogen classes.
Gene References into Functions
  1. we have found GBP1 was downregulated during osteogenic differentiation of hBM-MSCs. While knockdown of GBP1 promoted osteogenesis, overexpression of GBP1 suppressed osteogenesis of hBM-MSCs. PMID: 29348519
  2. Here, we show that the human protein GBP1 acts as a cytosolic "glue trap," capturing cytosolic Gram-negative bacteria through a unique protein motif and preventing disseminated infections in cell culture models. To escape from this GBP1-mediated host defense, Shigella employs a virulence factor that prevents or dislodges the association of GBP1 with cytosolic bacteria. PMID: 29233899
  3. Results show that GBP1 is overexpressed in triple-negative breast cancer (TNBC), under the control of EGFR and selectively affects the growth of TNBC cell lines. PMID: 29115931
  4. hGBP1F acts as a nucleotide-controlled molecular switch by modulating the accessibility of its farnesyl moiety, which does not require any supportive proteins PMID: 28645896
  5. These findings confirm the involvement of caspase-1 in non-classical secretion mechanisms and open novel perspectives for the extracellular function of secreted GBP-1. PMID: 28272793
  6. Results suggest that guanylate-binding protein 1 (GBP1) plays a pivotal role in anti-T. gondii protection of mesenchymal stromal cells (hMSCs) and may shed new light on clarifying the mechanism of host defense properties of hMSCs. PMID: 28123064
  7. Shigella flexneri infection induces rapid proteasomal degradation of human guanylate binding protein-1 (hGBP1); the mode of IpaH9.8 action highlights the functional importance of GBPs in antibacterial defenses PMID: 29144452
  8. Previously reported tetrameric and dimeric species of hGBP-1 and hGBP-5 were unmasked as dimers and monomers, respectively, with their shapes depending on both the bound nucleotide and the ionic strength of the solution. PMID: 28580591
  9. Taken together, these results provide a new understanding of the antiviral mechanism of human GBP1, which possesses potent anti-Kaposi's sarcoma-associated herpesvirus activity, and suggest the critical role of viral RTA in the evasion of the innate immune response during primary infection by Kaposi's sarcoma-associated herpesvirus. PMID: 28592529
  10. A novel role for hGBP1 in cell-autonomous immunity that is independent of pathogen-containing vacuole translocation. PMID: 26874079
  11. Elevated hGBP-1 RNA in ovarian tumors correlates with shorter recurrence-free survival. hGBP-1 does not confer paclitaxel resistance on MCF-7 and TMX2-28 breast cancer cells. PMID: 27590579
  12. the study not only highlights the importance of hGBP1 tetramer in stimulated GMP formation, but also demonstrates its role in the antiviral activity against hepatitis C virus. PMID: 27071416
  13. GBP1 expression is elevated in human Glioblastoma multiforme tumors and positively correlates with EGFRvIII status in Glioblastoma multiforme specimens, and its expression is inversely correlated with the survival rate of Glioblastoma multiforme patients. Taken together, these results reveal that GBP1 may serve as a potential therapeutic target for Glioblastoma multiforme with EGFRvIII mutation. PMID: 26848767
  14. GBP1 promotes lymph node metastasis and has a positive correlation with EGFR expression in esophageal squamous cell carcinoma. PMID: 26760981
  15. Molecular dynamics studies showed that only GTP decreases the formation of the GBP1:PIM1 complex through an allosteric mechanism, outlining the rational for the identification of new compounds potentially able to revert resistance to paclitaxel. PMID: 25081641
  16. GBP1 overexpression is necessary for the radioresistant phenotype in clinically relevant radioresistant cells PMID: 25098609
  17. data show that dimer formation of hGBP1 involves multiple spatially distant regions of the protein, namely, the N-terminal LG domain and the C-terminal helices alpha13. PMID: 24991938
  18. GBP-1 is a downstream processor of IFN-gamma. PMID: 24337748
  19. GBP-1 is a novel member within the family of actin-remodeling proteins specifically mediating IFN-gamma-dependent defense strategies. PMID: 24190970
  20. IFN-gamma-induced Guanylate Binding Protein-1 is a novel Actin Cytoskeleton Remodeling Factor. GBP-1 may induce actin remodeling via globular actin sequestering and/or filament capping. GBP-1 is a novel member within the family of actin remodeling proteins, specifically mediating IFN-gamma-dependent defense strategies. PMID: 24190970
  21. Data indicate that among three deductive p53 response element (p53RE) present in the hGBP1 promoter region, two p53REs were found to be transactivated by p53. PMID: 23727578
  22. GBP1/2 are critical effectors of antichlamydial interferon (IFN)gamma-mediated pathogen clearance via rerouting of bacterial inclusions in macrophages for lysosomal degradation. PMID: 23086406
  23. Thermodynamic insight as to how the stability of an intermediate catalytic complex regulates the product formation in hGBP1. PMID: 22859948
  24. Cytokine-induced GBP-1 retards cell proliferation by forming a negative feedback loop that suppresses beta-catenin / TCF signaling. PMID: 22692453
  25. results suggested that GBP-1 acts directly as a tumor suppressor in CRC and the loss of GBP-1 expression might indicate tumor evasion from the IFN-gamma-dominated Th1 immune response. PMID: 23042300
  26. GBP1 inhibits proliferation, migration, invasion and tumor formation of colon tumor cells. PMID: 23042300
  27. Data indicate that alpha12/13 represents a stable subdomain of guanylate-binding protein 1 (hGBP1). PMID: 22607347
  28. Data indicate that GBP1 guanine cap (i.e., C-terminal guanine-binding amino acid motif, particularly Arg240/Arg244) is key structural element responsible for dimerization and is essential for self-activation of GTPase activity. PMID: 22059445
  29. higher GBP1 level in oral cavity squamous cell carcinoma tissue was associated with higher overall pathological stage, positive perineural invasion, and poorer prognosis PMID: 21714544
  30. establish GBP1 as a previously unknown link between EGFR activity and MMP1 expression and nominate it as a novel potential therapeutic target for inhibiting GBM invasion. PMID: 22162832
  31. Data indicate that GBP-1 contributes to vascular dysfunction in chronic inflammatory diseases by inhibiting endothelial progenitor cell (EPC) angiogenic activity via the induction of premature EPC differentiation. PMID: 20716116
  32. GBP-1 cellular 1ocalization depends on prenylation and dimerization. PMID: 21151871
  33. hGBP-1, hGBP-2 showed dimerization-related GTPase activity for GMP formation. PMID: 20923658
  34. Animals carrying murine mammary carcinoma cells that had been given doxycycline for induction of human GBP-1 expression revealed a significantly reduced tumor growth compared with mock-treated mice. PMID: 20454519
  35. Results identify intramolecular contacts of guanylate binding protein 1, which relay nucleotide-dependent structural changes from the N-terminus to the C-terminus and thereby mediate tetramer formation of the protein. PMID: 20450919
  36. These findings identify a role for IFN-alphaA-mediated GBP-1 expression in the prevention of intestinal epithelial apoptosis by commensal bacteria. PMID: 20483731
  37. designed point mutants in the phosphate-binding loop (P-loop) as well as in the switch I and switch II regions. These mutant proteins were analysed for their interaction with guanine nucleotides and for their ability to hydrolyse GTP. PMID: 15504415
  38. Golgi targeting of human guanylate-binding protein-1 requires nucleotide binding, isoprenylation, and an IFN-gamma-inducible cofactor. PMID: 15937107
  39. GBP-1 regulates anti-proliferative effect of inflammatory cytokines. It also mediates inhibition of endothelial cell invasiveness by down regulation of MMP-1[review] PMID: 16005050
  40. crystal structures of the N-terminal G domain trapped at successive steps along the reaction pathway and biochemical data reveal the molecular basis for nucleotide-dependent homodimerization and cleavage of GTP PMID: 16511497
  41. kinetic investigation of GTP hydrolysis catalyzed by interferon-gamma-induced hGBP1 PMID: 16873363
  42. Interferon-alpha upregulates GBP1 in cultured human vascular endothelial cells. PMID: 16894355
  43. 3 genes were upregulated in patients with chronic EBV infection: guanylate binding protein 1, tumor necrosis factor-induced protein 6, and guanylate binding protein 5; they may be associated with the inflammatory reaction or with cell proliferation. PMID: 18260761
  44. GBP-1 may be a novel biomarker and an active component of a Th-1-like angiostatic immune reaction in colorectal carcinoma. PMID: 18697200
  45. GBP-1 is a novel marker of intestinal mucosal inflammation that may protect against epithelial apoptosis induced by inflammatory cytokines and subsequent loss of barrier function PMID: 19079332
  46. The authors demonstrate for the first time that both the alpha-helix of the intermediate region and the (103)DXEKGD(108) motif play critical roles for the hydrolysis to GMP. PMID: 19150356
  47. The results indicate that the GBP1, STAT1 and CXCL10 may be novel risk genes for the differentiation of PBM at the monocyte stage. PMID: 19223260
  48. Positions of cysteine residues buried between the C-terminal domain of GBP1 and the rest of the protein are identified which report a large change of accessibility by the compound after addition of GTP. PMID: 19463820
  49. Inhibition of endothelial cell spreading and migration by inflammatory cytokines is mediated by GBP-1 through induction of ITGA4 expression. PMID: 18697840
  50. Human guanylate binding protein-1 may be a useful surrogate marker for diagnosis of bacterial meningitis PMID: 16936281

Show More

Hide All

Subcellular Location Cytoplasm, Golgi apparatus membrane, Lipid-anchor, Cytoplasmic side, Cell membrane, Secreted
Protein Families TRAFAC class dynamin-like GTPase superfamily, GB1/RHD3-type GTPase family, GB1 subfamily
Database Links

HGNC: 4182

OMIM: 600411

KEGG: hsa:2633

STRING: 9606.ENSP00000359504

UniGene: Hs.62661


Get all the latest information on Events, Sales and Offers. Sign up for newsletter today.

© 2007-2021 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1